Orlifit™
Therapeutic Segment:
Anti-Obesity
Generic Name:
Orlistat
Indication
Capsule
- 120MG
Indicated for:
• Dietary modification (reduced calorie diet) in the management of obesity, i.e. in patients with a BMI of 30Kg/m2 or greater
• Overweight patients with BMI of 27Kg/m2 or more with associated risk factors e.g., (hypertension, diabetes, dyslipidemia).